Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site

MLA

Daniel Stadlbauer, et al. “Antibodies Targeting the Neuraminidase Active Site Inhibit Influenza H3N2 Viruses with an S245N Glycosylation Site.” Nature Communications, vol. 13, no. 1, Dec. 2022, pp. 1–8. EBSCOhost, https://doi.org/10.1038/s41467-022-35586-7.

APA

Daniel Stadlbauer, Meagan McMahon, Hannah L. Turner, Xueyong Zhu, Hongquan Wan, Juan Manuel Carreño, George O’Dell, Shirin Strohmeier, Zain Khalil, Marta Luksza, Harm van Bakel, Viviana Simon, Ali H. Ellebedy, Ian A. Wilson, Andrew B. Ward, & Florian Krammer. (2022). Antibodies targeting the neuraminidase active site inhibit influenza H3N2 viruses with an S245N glycosylation site. Nature Communications, 13(1), 1–8. https://doi.org/10.1038/s41467-022-35586-7

Chicago

Daniel Stadlbauer, Meagan McMahon, Hannah L. Turner, Xueyong Zhu, Hongquan Wan, Juan Manuel Carreño, George O’Dell, et al. 2022. “Antibodies Targeting the Neuraminidase Active Site Inhibit Influenza H3N2 Viruses with an S245N Glycosylation Site.” Nature Communications 13 (1): 1–8. doi:10.1038/s41467-022-35586-7.